Interventional: Page 100

Stereotaxis appoints new CMO
By AuntMinnie.com staff writers
Image-guided interventional surgery firm Stereotaxis of St. Louis has appointed a new chief medical officer (CMO), the company said.
January 16, 2008
AngioDynamics debuts new hemodialysis catheter
By AuntMinnie.com staff writers
Interventional technology developer AngioDynamics of Queensbury, NJ, has launched a new catheter for the treatment of cancer and peripheral vascular disease, the company reported.
January 16, 2008
Minrad makes two exec appointments
By AuntMinnie.com staff writers
Minrad International has named Charles Trego Jr. as its new chief financial officer (CFO) and executive vice president, effective March 3.
January 14, 2008
Cordis wins heart stent patent appeal
By AuntMinnie.com staff writers
Johnson & Johnson subsidiary Cordis of Miami Lakes, FL, has won an appeal in its patent battle with Medtronic and Boston Scientific over who owns heart stent patents, Reuters reported.
January 10, 2008
Medtronic launches stent graft product
By AuntMinnie.com staff writers
Interventional technology firm Medtronic has debuted a stent graft for its Xcelerant Hydro delivery system, the Minneapolis company reported.
January 9, 2008
Boston Scientific sells two more units
By AuntMinnie.com staff writers
Interventional device developer Boston Scientific of Natick, MA, has completed the sale of its cardiac surgery and vascular surgery businesses to a Swedish investment group.
January 6, 2008
AngioDynamics reports Q2 growth
By AuntMinnie.com staff writers
Interventional technology developer AngioDynamics of Queensbury, NJ, posted growth in sales and net income for the company's second quarter of fiscal 2008 (end-November 30).
January 3, 2008
BioSphere nets CE Mark OK
By AuntMinnie.com staff writers
Interventional device developer BioSphere Medical has received the European CE Mark for transarterial chemoembolization (TACE) of hepatocellular carcinoma (HCC) using its HepaSphere microspheres.
December 17, 2007
Medtronic begins Endurant trial
By AuntMinnie.com staff writers
Interventional technology firm Medtronic has begun the first human study of its Endurant stent graft system for the treatment of abdominal aortic aneurysm (AAA).
December 16, 2007
Boston Scientific to spin off businesses
By AuntMinnie.com staff writers
Interventional device developer Boston Scientific of Natick, MA, has signed an agreement with Avista Capital Partners to sell its fluid management and venous access businesses.
December 13, 2007
Volcano to buy CardioSpectra
By AuntMinnie.com staff writers
With an eye on broadening its presence in the interventional medicine market, intravascular ultrasound developer Volcano has signed an agreement to acquire optical coherence tomography (OCT) developer CardioSpectra of San Antonio for $25 million in cash.
December 12, 2007
FDA reports RF ablation deaths
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) has issued a Public Health Notification regarding reported deaths following radiofrequency (RF) ablation of lung tumors.
December 11, 2007
Previous Page
Page 100 of 184
Next Page